IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Hayman Capital Management, L.P.

Q3 2015 Holdings

Filed 2015-11-16 | 14 holdings | $13.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$13.6M129,50198.5%
NMI Hldgs Inc(NMIH)CL A629209305$56.0K7,371,5000.4%
YPF Sociedad Anonima(YPF)CallSPON ADR CL D984245100$34.3K2,250,0000.2%
Impax Laboratories IncCOM45256B101$21.4K606,6180.2%
CF Inds Hldgs Inc(CF)COM125269100$20.8K464,1010.2%
GW Pharmaceuticals PLCADS36197T103$19.3K210,7150.1%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$10.4K100,0000.1%
DBV Technologies S ASPONSORED ADR23306J101$9.4K265,3760.1%
Pronai Therapeutics IncCOM74346L101$8.7K422,2000.1%
ECO Stim Energy Solutions inCOM27888D101$7.3K2,130,0000.1%
Allergan PLCSHSG0177J108$4.8K17,8130.0%
Alcobra LTDSHSM2239P109$3.8K625,7920.0%
Endo Intl PLCSHSG30401106$3.6K52,6340.0%
Mylan N VSHS EURON59465109$3.2K78,9050.0%